Faculty Summaries
Lainie P Martin, MD
Lainie P Martin, MD
Assistant Professor

Publications

  • Seiwert TY, Jagadeeswaran R, Faoro L, Janamanchi V, Nallasura V, El Dinali M, Yala S, Kanteti R, Cohen EEW, Lingen MW, Martin L, Krishnaswamy S, Klein-Szanto A, Christensen JG, Vokes EE, Salgia R. The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer Res. 2009;69:3021-3031.
  • Martin LP, Schilder RJ. Management of recurrent ovarian carcinoma: current status and future directions. Semin Oncol. 2009;36:112-125.
  • Martin LP, Hamilton TC, Schilder RJ. Platinum resistance: The role of DNA repair pathways. Clin Cancer Res. 2008;14:1291-1295. Accepted prior to April 7, 2008
  • Martin L, Schilder R. Novel approaches in advancing the treatment of epithelial ovarian cancer: the role of angiogenesis inhibition. J Clin Oncol. 2007;25:2894-2901.
  • Martin LP, Schilder RJ. The role of pertuzumab in ovarian cancer: Phase I development and preclinical rationale. Physician's Education Resource. Targeted Therapies in Oncology 2006 Mar;5(1).
  • Martin L, Schilder RJ. Novel non-cytotoxic therapy in ovarian cancer: Current status and future prospects. J Natl Compr Canc Netw. 2006;4:955-966.
  • Martin L, Schilder RJ. Front-line treatment of epithelial ovarian cancer: Focus on the medical oncologists' perspective. Am J Cancer. 2005;4:221-231.
  • Martin L, Schilder RJ. Front-line treatment of epithelial ovarian cancer: Focus on the medical oncologists' perspective. Am J Cancer. 2005;4:221-231.